Drospirenone
Depression, Anxiety
Fudan UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Depression, Anxiety cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Hepatitis B Virus Vaccine Eunice Dube | Phase 4 | BB |
Gardasil 9 Vaccine Eunice Dube | Phase 4 | BB |
Azithromycin University of California, San Francisco | Phase 4 | BB |
Vitamin B6 Mclean Hospital | Phase 2 | CCC |
MAGNESIUM METALLICUM Mclean Hospital | Phase 2 | CCC |
View all 21 →
Same molecule, other indications
Drospirenone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →